Chatzellis, E. Daskalakis, K. Angelousi, A. Tsoli, M. Alexandraki, K.I. Wachula, E. Meirovitz, A. Maimon, O. Grozinsky-Glasberg, S. Gross, D. Kos-Kudła, B. Koumarianou, A. Kaltsas, G., Authors' Response to the Letter by Lamarca et al. Entitled "temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms", ISRN Neuroendocrinology, (110), 158-160, 2020, S Karger AG, 2090-7982